Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care
Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care
Blog Article
Introduction: Although post-COVID-19 syndrome (PCS) with cognitive impairment is increasingly encountered in primary care, evidence-based recommendations for its appropriate management are lacking.Methods: A systematic literature search evaluating the diagnosis and treatment of cognitive impairment associated with PCS was conducted.Practical recommendations for the management of PCS-associated cognitive impairment in primary care are summarized, based on an evaluation of pharmacological plausibility and clinical applications.Results: Currently, the pathology of cognitive impairment associated Multi-Tools with PCS remains unclear with no high-quality data to support targeted interventions.Existing treatment approaches are directed towards symptom relief where counseling on the chronicity of the disease and regular reassessments at 4- to 8-week intervals is considered reasonable.
Patients should be informed and encouraged to adopt a healthy lifestyle that centers around balanced nutrition and appropriate physical activities.They may also benefit from the intake of vitamins, micronutrients, and probiotics.The administration of Ginkgo biloba extract could offer a safe and potentially beneficial treatment option.Other non-pharmacological measures include physiotherapy, digitally supported cognitive training, and, if indicated, ergotherapy or speech therapy.In most patients, symptoms improve within 8 weeks.
If serious, ambiguous, or when new symptoms occur, specialized diagnostic measures such as comprehensive neurocognitive testing or neuroimaging should be initiated.Very few Hobby Paint patients would require inpatient rehabilitation.Conclusion: PCS with cognitive impairment is a debilitating condition that could affect daily functioning and reduce work productivity.Management in primary care should adopt a multidisciplinary approach, centering around physical, cognitive, and pharmacological therapies.